bredesensprotocol.com - Dr. Dale Bredesen - Chief Science Officer At Apollo Health

Description: Dr. Dale Bredesen’s career has been guided by a simple idea: Alzheimer’s as we know it is not just preventable, but reversible.

Example domain paragraphs

Get Started Free Cq Assessment Solutions for Cognitive Decline PreCODE ReCODE Find a Practitioner or Coach Health Coaching Support Groups Cognoscopy LifeSeasons Supplements FAQs For Providers For Practitioners ReCODE 2.0 Training ReCODE 2.0 Dental Training ReCODE Center of Excellence For Coaches ReCODE 2.0 Training Training FAQs Evidence About The Bredesen Protocol To Our Critics Clinical Trial Results 2022 ReCODE Data Analysis Multifactorial Rationale Publications Testimonials Education Core Components The

Dr. Bredesen earned his M.D. from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.

Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results . Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017  New York   Times ‘ Be